Jamie Raskin actually said...

"this is precisely why we need to give the government and Medicare the power to negotiate for lower drug prices because our patients and our taxpayers are getting ripped off by big pharma."

"Thank you very much, Madam Chair, for calling this extremely important hearing."

"Your company has made more than $34 billion--$34 billion--from Copaxone but it reported to the committee that it has spent two percent of that on R&D expenditures for Copaxone patients."

"In just a little example, Copaxone cost our constituents $126 a day, which is four times what it costs in Germany."